View in EDS HTML Full Text PDF Full Text

Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.

Saved in:
Bibliographic Details
Title: Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.
Authors: Verbeek MWC; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands., Reiterová M; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic., Laqua A; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany., Rodríguez BS; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain., Sedek L; Department of Microbiology and Immunology Medical University of Silesia Katowice Poland.; Department of Pediatric Hematology and Oncology Medical University of Silesia Katowice Poland., Buracchi C; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori Monza Italy., Buysse M; Department of Diagnostic Sciences Ghent University Ghent Belgium.; Department of Laboratory Medicine Ghent University Hospital Ghent Belgium., Oliveira E; Faculty of Medicine Pediatrics Institute IPPMG Federal University of Rio de Janeiro Rio de Janeiro Brazil., Engelmann R; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical Center Rostock Germany., Desterro J; Instituto Português de Oncologia de Lisboa Francisco Gentil, Rua Prof Lima Basto Lisboa Portugal., De Jong AX; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Boettcher S; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical Center Rostock Germany., Jugooa R; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands., Barrena S; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain., Kohlscheen S; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Rodriques JG; Instituto Português de Oncologia de Lisboa Francisco Gentil, Rua Prof Lima Basto Lisboa Portugal., Hofmans M; Department of Diagnostic Sciences Ghent University Ghent Belgium.; Department of Laboratory Medicine Ghent University Hospital Ghent Belgium., Gaipa G; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori Monza Italy., Sobral de Costa E; Faculty of Medicine Pediatrics Institute IPPMG Federal University of Rio de Janeiro Rio de Janeiro Brazil., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic., Szczepanski T; Department of Pediatric Hematology and Oncology Medical University of Silesia Katowice Poland., Brüggemann M; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany., van Dongen JJM; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain.; Department of Immunology LUMC Leiden The Netherlands., Orfao A; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain., van der Velden VHJ; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.
Source: HemaSphere [Hemasphere] 2025 Apr 13; Vol. 9 (4), pp. e70125. Date of Electronic Publication: 2025 Apr 13 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40224162
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Verbeek+MWC%22">Verbeek MWC</searchLink>; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Reiterová+M%22">Reiterová M</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic.<br /><searchLink fieldCode="AU" term="%22Laqua+A%22">Laqua A</searchLink>; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Rodríguez+BS%22">Rodríguez BS</searchLink>; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain.<br /><searchLink fieldCode="AU" term="%22Sedek+L%22">Sedek L</searchLink>; Department of Microbiology and Immunology Medical University of Silesia Katowice Poland.; Department of Pediatric Hematology and Oncology Medical University of Silesia Katowice Poland.<br /><searchLink fieldCode="AU" term="%22Buracchi+C%22">Buracchi C</searchLink>; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori Monza Italy.<br /><searchLink fieldCode="AU" term="%22Buysse+M%22">Buysse M</searchLink>; Department of Diagnostic Sciences Ghent University Ghent Belgium.; Department of Laboratory Medicine Ghent University Hospital Ghent Belgium.<br /><searchLink fieldCode="AU" term="%22Oliveira+E%22">Oliveira E</searchLink>; Faculty of Medicine Pediatrics Institute IPPMG Federal University of Rio de Janeiro Rio de Janeiro Brazil.<br /><searchLink fieldCode="AU" term="%22Engelmann+R%22">Engelmann R</searchLink>; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical Center Rostock Germany.<br /><searchLink fieldCode="AU" term="%22Desterro+J%22">Desterro J</searchLink>; Instituto Português de Oncologia de Lisboa Francisco Gentil, Rua Prof Lima Basto Lisboa Portugal.<br /><searchLink fieldCode="AU" term="%22De+Jong+AX%22">De Jong AX</searchLink>; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.<br /><searchLink fieldCode="AU" term="%22Boettcher+S%22">Boettcher S</searchLink>; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical Center Rostock Germany.<br /><searchLink fieldCode="AU" term="%22Jugooa+R%22">Jugooa R</searchLink>; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Barrena+S%22">Barrena S</searchLink>; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain.<br /><searchLink fieldCode="AU" term="%22Kohlscheen+S%22">Kohlscheen S</searchLink>; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Nierkens+S%22">Nierkens S</searchLink>; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodriques+JG%22">Rodriques JG</searchLink>; Instituto Português de Oncologia de Lisboa Francisco Gentil, Rua Prof Lima Basto Lisboa Portugal.<br /><searchLink fieldCode="AU" term="%22Hofmans+M%22">Hofmans M</searchLink>; Department of Diagnostic Sciences Ghent University Ghent Belgium.; Department of Laboratory Medicine Ghent University Hospital Ghent Belgium.<br /><searchLink fieldCode="AU" term="%22Gaipa+G%22">Gaipa G</searchLink>; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori Monza Italy.<br /><searchLink fieldCode="AU" term="%22Sobral+de+Costa+E%22">Sobral de Costa E</searchLink>; Faculty of Medicine Pediatrics Institute IPPMG Federal University of Rio de Janeiro Rio de Janeiro Brazil.<br /><searchLink fieldCode="AU" term="%22Mejstrikova+E%22">Mejstrikova E</searchLink>; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic.<br /><searchLink fieldCode="AU" term="%22Szczepanski+T%22">Szczepanski T</searchLink>; Department of Pediatric Hematology and Oncology Medical University of Silesia Katowice Poland.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Hematology University of Schleswig-Holstein, Campus Kiel Kiel Germany.<br /><searchLink fieldCode="AU" term="%22van+Dongen+JJM%22">van Dongen JJM</searchLink>; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain.; Department of Immunology LUMC Leiden The Netherlands.<br /><searchLink fieldCode="AU" term="%22Orfao+A%22">Orfao A</searchLink>; Translational and Clinical Research Program, Department of Medicine Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS University of Salamanca (USAL) Salamanca Spain.; Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III Madrid Spain.<br /><searchLink fieldCode="AU" term="%22van+der+Velden+VHJ%22">van der Velden VHJ</searchLink>; Department of Immunology Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 Apr 13; Vol. 9 (4), pp. e70125. <i>Date of Electronic Publication: </i>2025 Apr 13 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40224162
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70125
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70125
    Titles:
      – TitleFull: Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Verbeek MWC
      – PersonEntity:
          Name:
            NameFull: Reiterová M
      – PersonEntity:
          Name:
            NameFull: Laqua A
      – PersonEntity:
          Name:
            NameFull: Rodríguez BS
      – PersonEntity:
          Name:
            NameFull: Sedek L
      – PersonEntity:
          Name:
            NameFull: Buracchi C
      – PersonEntity:
          Name:
            NameFull: Buysse M
      – PersonEntity:
          Name:
            NameFull: Oliveira E
      – PersonEntity:
          Name:
            NameFull: Engelmann R
      – PersonEntity:
          Name:
            NameFull: Desterro J
      – PersonEntity:
          Name:
            NameFull: De Jong AX
      – PersonEntity:
          Name:
            NameFull: Boettcher S
      – PersonEntity:
          Name:
            NameFull: Jugooa R
      – PersonEntity:
          Name:
            NameFull: Barrena S
      – PersonEntity:
          Name:
            NameFull: Kohlscheen S
      – PersonEntity:
          Name:
            NameFull: Nierkens S
      – PersonEntity:
          Name:
            NameFull: Rodriques JG
      – PersonEntity:
          Name:
            NameFull: Hofmans M
      – PersonEntity:
          Name:
            NameFull: Gaipa G
      – PersonEntity:
          Name:
            NameFull: Sobral de Costa E
      – PersonEntity:
          Name:
            NameFull: Mejstrikova E
      – PersonEntity:
          Name:
            NameFull: Szczepanski T
      – PersonEntity:
          Name:
            NameFull: Brüggemann M
      – PersonEntity:
          Name:
            NameFull: van Dongen JJM
      – PersonEntity:
          Name:
            NameFull: Orfao A
      – PersonEntity:
          Name:
            NameFull: van der Velden VHJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 04
              Text: 2025 Apr 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1